[Aspects of antiviral therapy in herpes infections].
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D001380:Azauridine / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004660:Encephalitis / Q000188:drug therapy; D005467:Floxuridine / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007136:Immunoglobulins / Q000627:therapeutic use; D007167:Immunotherapy; D007369:Interferon Inducers / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy
D000998:Antiviral Agents; D007136:Immunoglobulins; D007369:Interferon Inducers; D005467:Floxuridine; D003561:Cytarabine; D001380:Azauridine; D007065:Idoxuridine
Aspecte ale terapiei antivirale în infecţia herpetică.